The Role of Endocan Level in Determining Large and Small Vessel Occlusion in Acute Ischemic Stroke
Open Access
- 2 March 2026
- journal article
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 58 (2) , 1-4
Abstract
Background: Stroke is a clinical condition in which blood flow to a brain area is interrupted by occlusion or hemorrhage. At present, the diagnosis and treatment of stroke are based on the use of biochemical markers and imaging methods. The degree of inflammation in the vessel wall may be reflected by changes in endocan levels. The aim of this study was the investigation of the role of endocan blood levels in the determination of large- and small-vessel occlusion in acute ischemic stroke. Methods: This was a prospective, single-center clinical study. Sociodemographic characteristics, physical examination, laboratory findings, and endocan levels were recorded. Patients with ischemic stroke were categorized as large-vessel occlusive (LVO) or small-vessel occlusive (SVO) on computed tomography (CT) angiography. Blood endocan levels were compared between the 2 groups. Results: A total of 110 patients were included in the study; the mean age of these patients was 69.2 years and 50.5% were male. Large-vessel occlusive was present in 33.3% (n = 31) of these patients, and endocan levels were higher in the LVO group but without statistical significance (P > .05). Modified Rankin Score was higher in the LVO group while Glasgow Coma Score was lower and both were statistically significant (P < .001). The area under the receiver-operating characteristic (ROC) curve for troponin was 0.762 and statistically significant (P = .001). Conclusion: Serum endocan levels did not differ significantly between LVO patients and controls. However, more research is needed to determine how significant these high endocan levels are in diagnosing major artery disease. Cite this article as: Tekin E, Çelik M, Tortum F, et al. The role of endocan level in determining large and small vessel occlusion in acute ischemic stroke. Eurasian J Med. 2026, 58(2), 1094, doi: 10.5152/ eurasianjmed.2026.251094.Keywords
This publication has 15 references indexed in Scilit:
- Novel Biomarkers for Evaluation of Endothelial DysfunctionAngiology, 2020
- Serum levels of endocan and endoglin are associated with large-artery atherosclerotic strokeClinica Chimica Acta, 2018
- Admission Endocan Level may be a Useful Predictor for In-Hospital Mortality and Coronary Severity Index in Patients With ST-Segment Elevation Myocardial InfarctionAngiology, 2016
- Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF BioavailabilityCirculation Research, 2014
- Serum Endocan Level and the Severity of Coronary Artery DiseaseAngiology, 2014
- Serum endocan levels as a marker of disease activity in patients with Behçet diseaseJournal of the American Academy of Dermatology, 2014
- Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In VivoJournal of Cellular Physiology, 2013
- Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of diseaseBritish Journal of Dermatology, 2013
- Endocan, a new endothelial marker in human sepsis*Critical Care Medicine, 2006
- Human Endothelial-Cell Specific Molecule-1 Binds Directly to the Integrin CD11a/CD18 (LFA-1) and Blocks Binding to Intercellular Adhesion Molecule-1The Journal of Immunology, 2001